Cnidus Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.90 M
- Paid Up Capital ₹ 1.60 M
- Company Age 19 Year, 8 Days
- Last Filing with ROC 31 Mar 2012
About Cnidus Pharma
Cnidus Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 February 2006 and has a history of 19 years. Its registered office is in Thrissur, Kerala, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 1.90 M and a paid-up capital of Rs 1.60 M, as per Ministry of Corporate Affairs (MCA) records.
George John, Sha Mathew, George Jacob, and Eight other members serve as directors at the Company.
Company Details
- Location
Thrissur, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232KL2006PTC019188
- Company No.
019188
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Feb 2006
- Date of AGM
29 Sep 2012
- Date of Balance Sheet
31 Mar 2012
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Cnidus Pharma?
Board Members (11)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
George John  | Director | 01-Aug-2008 | Current |
| Sha Mathew | Director | 01-Aug-2008 | Current |
| George Jacob | Director | 01-Aug-2008 | Current |
| Chacko Mattathil | Director | 01-Aug-2008 | Current |
| Francis Thomas | Director | 29-Sep-2011 | Current |
| Jeena George | Director | 29-Sep-2011 | Current |
Financial Performance of Cnidus Pharma.
Enhance accessibility to Cnidus Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cnidus Pharma?
Unlock access to Cnidus Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cnidus Pharma?
Cnidus Pharma has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cnidus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cnidus Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
